Biomarker Test may lead to New Mesothelioma Drug

by Shrader Law | Apr 3, 2013 | Mesothelioma

A company that makes cancer stem-cell treatments is preparing to test a new mesothelioma drug. The company, Verastem, Inc., specializes in creating agents that kill cancer stem cells. One of the company’s medicines, VS-6063, is a focal adhesion kinase inhibitor which will be involved in a mesothelioma study later this year. Pfizer, the original developer of this drug, already conducted a Phase 1...

View Article

After Deadly Earthquake, New Zealand City Calls for Asbestos Registry

by Shrader Law | Apr 3, 2013 | Mesothelioma

After an earthquake damaged more than 4,000 homes in Christchurch, New Zealand, some government officials and concerned citizens have proposed the compilation of an asbestos registry to identify homes that may contain the toxic mineral. Asbestos exposure is the cause of a number of potentially fatal diseases, including the deadly form of cancer known as mesothelioma. The local government has...

View Article